NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...

Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square ...

Why industry needs to engage earlier, explain value more clearly, understand service pressures and take shared responsibility ...

Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary ...

The annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership ...

The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity ...

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments ...

MSD, known as Merck in the US and Canada, has announced the first presentation of results from MK-7240-012, a phase 2b ...

In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership ...